New innovative multifunctional polymer from Seppic combines robust formulation performance with optimised sensory properties
Formulators of the dermo-pharmaceutical products continuously face complex challenges including developing stable formulations, ensuring compatibility with different technologies, managing demanding APIs, and supporting patient compliance. In response to these requirements, Seppic has introduced SEPINEO™ PRD 100, a next-generation polymer for topical drug dosage forms.
This innovative multifunctional polymer provides thickening and texturising performance and is specifically designed to perform reliably across a broad range of topical dosage forms even under challenging formulation conditions. SEPINEO™ PRD 100 delivers a transparent, rich, and velvety texture with a versatile viscosity profile, from sprayable to thick. This results in a highly desirable sensorial profile that contribute directly to improved patient acceptance and compliance.
For formulators, the polymer’s pre-neutralized nature and excellent co-stabilising properties streamline development by reducing processing steps and formulation complexity and iterations. Its distinctive rheological profile, combined with its unique texture, makes SEPINEO™ PRD 100 particularly well suited of innovative topical drug dosage forms such as refined foams and sprayable solutions.
Designed to support the development of stable topical drug dosage forms containing demanding ingredients, SEPINEO™ PRD 100 provides a robust, stress-resistant solution that maintains stability under conditions such as electrolyte and solvent/oil-rich environments, or in the presence of stressor APIs.
SEPINEO™ PRD 100 complies with the most stringent quality standards, has a US DMF Type IV, and Seppic’s Richmond facility based in Virginia USA holds an ISO 9001 certification.
